
Quotient Limited – NASDAQ:QTNT
Quotient Limited stock price monthly change
Quotient Limited stock price quarterly change
Quotient Limited stock price yearly change
Quotient Limited key metrics
Market Cap | N/A |
Enterprise value | 262.07M |
P/E | -0.01 |
EV/Sales | 7.00 |
EV/EBITDA | -3.14 |
Price/Sales | 0.04 |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -48.02 |
Revenue | 38.51M |
EBITDA | -83.55M |
Income | -122.23M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -331.54% |
Oper. margin | -309.92% |
Gross margin | 0.75% |
EBIT margin | -309.92% |
EBITDA margin | -216.95% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeQuotient Limited stock price history
Quotient Limited stock forecast
Quotient Limited financial statements
Jun 2021 | 9.08M | -24.39M | -268.43% |
---|---|---|---|
Sep 2021 | 9.46M | -27.10M | -286.31% |
Dec 2021 | 10.17M | -44.82M | -440.63% |
Mar 2022 | 9.78M | -25.91M | -264.79% |
2022-06-24 | -13.6 | -10 |
---|---|---|
2022-08-09 | -8 | -14.8 |
2022-11-14 | -9.43 | -10.81 |
Payout ratio | 0% |
---|
2018 | 21.83% |
---|---|
2019 | 8.41% |
2020 | 14.85% |
2021 | |
2022 | 34.34% |
Mar 2022 | 193989000 | 338.08M | 174.28% |
---|---|---|---|
Jun 2022 | 174590000 | 325.66M | 186.53% |
Sep 2022 | 127905000 | 309.99M | 242.36% |
Dec 2022 | 119326000 | 328.21M | 275.05% |
Jun 2021 | -32.05M | 12.64M | 88.11M |
---|---|---|---|
Sep 2021 | -26.64M | 30.37M | -129K |
Dec 2021 | -69.53M | 14.27M | 87.92M |
Mar 2022 | -22.87M | -569K | -180K |
Quotient Limited alternative data
Aug 2023 | 450 |
---|---|
Sep 2023 | 450 |
Oct 2023 | 450 |
Nov 2023 | 450 |
Dec 2023 | 450 |
Jan 2024 | 450 |
Feb 2024 | 450 |
Mar 2024 | 450 |
Apr 2024 | 450 |
May 2024 | 450 |
Jun 2024 | 450 |
Jul 2024 | 450 |
Quotient Limited other data
Period | Buy | Sel |
---|---|---|
Dec 2021 | 50000 | 0 |
Jan 2022 | 0 | 3847 |
Feb 2022 | 60000 | 0 |
May 2022 | 0 | 4203 |
Jun 2022 | 218140 | 0 |
Jul 2022 | 0 | 4863 |
Sep 2022 | 1000000 | 0 |
Oct 2022 | 0 | 8255607 |
Nov 2022 | 0 | 26014 |
Quarter | Transcript |
---|---|
Q1 2023 9 Aug 2022 | Q1 2023 Earnings Call Transcript |
Q4 2022 24 Jun 2022 | Q4 2022 Earnings Call Transcript |
Q3 2022 8 Feb 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 9 Nov 2021 | Q2 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Peter Buhler (1970) Executive Officer | $761,150 |
-
When is Quotient Limited's next earnings date?
Unfortunately, Quotient Limited's (QTNT) next earnings date is currently unknown.
-
Does Quotient Limited pay dividends?
No, Quotient Limited does not pay dividends.
-
What is Quotient Limited's stock symbol?
Quotient Limited is traded on the NASDAQ under the ticker symbol "QTNT".
-
What is Quotient Limited's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Quotient Limited?
Shares of Quotient Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Quotient Limited's key executives?
Quotient Limited's management team includes the following people:
- Mr. Peter Buhler Executive Officer(age: 55, pay: $761,150)
-
How many employees does Quotient Limited have?
As Jul 2024, Quotient Limited employs 450 workers.
-
When Quotient Limited went public?
Quotient Limited is publicly traded company for more then 11 years since IPO on 16 Apr 2014.
-
What is Quotient Limited's official website?
The official website for Quotient Limited is quotientbd.com.
-
How can i contact Quotient Limited?
Quotient Limited can be reached via phone at +41 22 716 98 00.
Quotient Limited company profile:

Quotient Limited
quotientbd.comNASDAQ
450
Medical - Devices
Healthcare
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
, VAUD 1262
CIK: 0001596946
ISIN: JE00BLG2ZQ72
CUSIP: G73268107